JOIN US AT OUR TEXAS LARGEST JUDGED 1MILE, 3K, 5K & 10K RACE WALK PLUS 5K ANNUAL RUN

Translate to Spanish or other 102 languages!

Mega Date:                 Friday 1/2/15 and Saturday 1/3/15

- Advertisement -

Location:         5K & 10K Race Walk and 5K Run at Liberty Middle School

                           1212 S. Fir, Pharr, Texas 78577

                           1 Mile and 3K Race Walk at PSJA H.S. Stadium

- Advertisement -

                           600 E. Kelly, Pharr, Texas 78577

Starting Time  Friday       1/2/15 – 9:00 a.m. – 3K Race Walk (PSJA Stadium)

& Locations:   Friday       1/2/15 – 9:30 a.m. – 1 Mile Race Walk (PSJA Stadium)

                           Saturday  1/3/15 – 7:00 a.m. – 10K Race Walk – Liberty Middle School

- Advertisement -

                           Saturday  1/3/15 – 8:15 a.m. – 5K Race Walk – Liberty Middle School

                           Saturday  1/3/15 – 9:00 a.m. – 5K Run – Liberty Middle School

Entry Fee:       $10.00 Pre – Registration by December 20, 2014

                           www.eteamz.com/stwc or

                           621 N. 10th, Ste C – McAllen for application

                           956-821-6659 for information

- Advertisement -
- Advertisement -

- Advertisement -

More Articles

American Cancer Society Updates Prostate Cancer Screening Guideline

The American Cancer Society (ACS) released an updated guideline for prostate cancer screening to help find cancer before it spreads and reduce the risk of dying from the disease.

FDA Approves First Factor Xla Inhibitor to Help Prevent Stroke in Certain Adults at High Risk 

The U.S. Food and Drug Administration today approved Sunharbo (asundexian) 50 mg tablets, the first factor XIa (FXIa) inhibitor for use in combination with antiplatelet therapy to reduce the risk of stroke in adults following a recent mild-to-moderate non-cardioembolic ischemic stroke (a stroke caused by a clot that did not originate in the heart) or a high-risk transient ischemic attack (TIA), often called a “mini-stroke.” 

Embolism Treatment Developed at University of Michigan receives FDA clearance 

Patients with persistent blood clots require frequent medical interventions just to survive. Yet despite this critical need, there have been few advancements in how these patients are treated. 

FDA Approves Once-Weekly Generic Hormone Therapy Patch for Women

The U.S. Food and Drug Administration approved the first generic of Climara Pro (estradiol and levonorgestrel transdermal system, 0.045 mg per day/0.015 mg), a transdermal hormone therapy patch for women with an intact uterus applied once a week. The approval aligns with FDA’s Public Health Pillar: Increasing Access to Affordable Medicines & Medical Products.
- Advertisement -